Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
/in International Publications, Newcastle Disease Virus /von 2014-08-12 / Front Oncol 2014;4:217Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-07-30 / BMC Cancer 2014 Jul;14:551ISG12a mediates cell response to Newcastle disease viral infection
/in International Publications, Newcastle Disease Virus /von 2014-07-05 / Virology 2014 Aug;462-463:283-94Going viral with cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response
/in International Publications, Newcastle Disease Virus /von 2014-06-18 / J. Immunol. 2014 Jul;193(2):735-45Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
/in International Publications, Newcastle Disease Virus /von 2014-06-11 / Front Oncol 2014;4:145Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3051)γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.
/in Dendritic Cells, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-05-12 / Virol. J. 2014 May;11:84IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de